Beneficial Effect of Systemic Allogeneic Adipose Derived Mesenchymal Cells on the Clinical, Inflammatory and Immunologic Status of a Patient With Recessive Dystrophic Epidermolysis Bullosa- A Case Report
Fate of Intravenously Injected Mesenchymal Stem Cells and Significance for Clinical Application
Intravenous allogeneic multilineage-differentiating stress-enduring cells in adults with dystrophic epidermolysis bullosa- a phase 1:2 open-label study
Safety and efficacy of autologous adipose tissue-derived stem cell transplantation in aging-related low-grade inflammation patients- a single-group, open-label, phase I clinical trial
Phase I:II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa
Autologous Infusion of Bone Marrow and Mesenchymal Stromal Cells in Patients with Chronic Obstructive Pulmonary Disease- Phase I Randomized Clinical Trial
Autologous adipose-derived stem cells therapy in COPD treatment- a case report
